Applied Cells

Executive Summary

Applied Cells is a privately held biotechnology company developing innovative cell isolation platforms for cell therapy manufacturing and cancer diagnostics. Its core MARS technology is a column-free, magnetic separation system designed to be faster, more cost-effective, and scalable than traditional methods. The company aims to accelerate the development of accessible diagnostic tools and cell therapies, with its GoFast™ workflow targeting CAR-T manufacturing. Founded in 2014 and headquartered in Santa Clara, California, Applied Cells operates in a competitive landscape where efficient, low-cost cell isolation is critical for scaling cell-based therapies. While the company has not disclosed funding or valuation, its technology addresses key bottlenecks in cell therapy production, including time and cost constraints.

Upcoming Catalysts (preview)

• Q4 2026Strategic partnership or licensing deal for MARS technology in cell therapy manufacturing40% success
• Q3 2026Series A or B funding round to support commercial scale-up50% success
• Q2 2027Launch of GoFast™ workflow for CAR-T into clinical use or new partnerships30% success